Skip to main content

Table 2 Complete response of CINV

From: Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

 

Complete response (%)

 

AN

AV

DN

DV

NC

VC

 

H

M

H

M

H

M

H

M

H

M

H

M

TG

94.64

98.46

91.07

96.92

69.64

83.07

78.57

89.23

69.64

83.07

78.57

89.23

CG

86.96

93.54

89.13

96.77

30.43

58.06

56.52

75.80

28.26

56.45

56.52

75.80

P value

> 0.05

> 0.05

< 0.05

< 0.05

< 0.05

< 0.05

  1. AN: acute nausea, AV: acute vomiting, DN: delayed nausea, DV: delayed vomiting, NC: nausea of whole period of chemotherapy, VC: vomiting of whole period of chemotherapy, TG: test group, CG: control group, H: highly emetogenic chemotherapy, M: moderately emetogenic chemotherapy